NYSE:TEVAPharmaceuticals
Teva (TEVA) Stock Looks Reasonable Even With A 48% Gap
Teva Pharmaceutical Industries stock has delivered a very strong 308.6% return over the past three years, while the Discounted Cash Flow (DCF) intrinsic value estimate still flags the shares as trading at a sizeable discount of 48.4% to that model, which contrasts with market multiples that look closer to fair.
Over three years, Teva Pharmaceutical Industries has returned 308.6%, which puts recent short term pullbacks into the context of a large prior re-rating.
Progress in higher margin...